Elicio Therapeutics
- Pharmaceutical Preparations
- Boston, Massachusetts
Compensation history
Top executives at Elicio Therapeutics received an average of $1M per person in annual compensation between 2022 and 2023.
Average pay of disclosed executives at Elicio Therapeutics
By year
- 2023
JV$2MJay R. Venkatesanformer Chief Executive Officer, President, and Chairman of the Angion BoardJR$1MJennifer J. Rhodesformer Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate SecretaryBP$879KBrian Piekosformer Chief Financial Officer and TreasurerRC$678KRobert ConnellyPresident, Chief Executive Officer, and DirectorCH$674KChristopher HaqqExecutive Vice President, Head of Research and Development and Chief Medical Officer- 2022
JV$2MJay R. Venkatesanformer Chief Executive Officer, President, and Chairman of the Angion BoardRC$1MRobert ConnellyPresident, Chief Executive Officer, and DirectorCH$1MChristopher HaqqExecutive Vice President, Head of Research and Development and Chief Medical OfficerJR$774KJennifer J. Rhodesformer Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
Executives
We found five executives who work or worked at Elicio Therapeutics.
News
About Elicio Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address451 D Street, 5th Floor, Boston, Massachusetts 02210
- Phone(857) 209-0050
- Fiscal year endDecember 31
- Former names
- Angion Biomedica Corp.Until May 29, 2023
Source: SEC filing on September 27, 2024.